Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.